1. EpiSwitch 3D-genomic blood test classified ME/CFS with 96% accuracy.
2. The model used 200 chromosomal conformation markers from whole-blood DNA.
3. Immune pathways involving IL-2, IL-10, and TNF/NF-kappaB were identified.
4. The study included validation in independent patient and control cohorts.
5. Findings suggest immune dysregulation and chromatin changes in ME/CFS.
6. Researchers called for larger multi-center studies to confirm results.

Source: Journal of Translational Medicine